Sign up to access historical data
Similar companies
| Company | Est. Transaction Value | |
|---|---|---|
 |
PfizerPFE |
-$71,000 |
 |
AstrazenecaAZN |
$32,000 |
 |
Johnson & JohnsonJNJ |
-$230,000 |
 |
ModernaMRNA |
$16,000 |
 |
AbbVieABBV |
$88,000 |
Trades by US Politicians
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Lisa McClain | Sep 11, 2025 | Sell | $1K - $15K |
| Lisa McClain | Jun 17, 2025 | Buy | $1K - $15K |
| Rohit Khanna Democrat | Apr 12, 2024 | Sell | $1K - $15K |
FAQ - Congress Trading
Lisa McClain sold Sanofi shares most recently on September 11, 2025.
Lisa McClain has bought the most SNY stock in the last 2 years, with an estimated value of $8,000.
Rohit Khanna has sold the most SNY stock in the last 2 years, with an estimated value of $8,000.
The net value of trades by US politicians for Sanofi in the last 2 years is negative, amounting to -$8,000. This suggests that US politicians do not believe in the success of the company for various reasons.
Over the last 2 years, insider transactions for Sanofi have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering politicians might have insights or reasons not immediately apparent to the public.
Monitoring US politicians' stock trades is valuable because they may have inside information about upcoming policies that could affect stock values, providing investors with valuable clues for making informed decisions.
